JP Morgan Chase
ONCR

JP Morgan Chase’s Oncorus, Inc. ONCR Stock Holding History

JP Morgan Chase’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-353
Closed – – 7493
2023
Q1 		$0 Hold
353
– – ﹤0.01% 7428
2022
Q4 		$0 Sell
353
-953
-73% -$542 ﹤0.01% 7216
2022
Q3 		$1K Buy
1,306
+310
+31% +$398 ﹤0.01% 6404
2022
Q2 		$1K Sell
996
-11,593
-92% -$15.7K ﹤0.01% 6412
2022
Q1 		$22K Sell
12,589
-33,595
-73% -$94.1K ﹤0.01% 6051
2021
Q4 		$243K Buy
46,184
+38,175
+477% +$296K ﹤0.01% 5240
2021
Q3 		$75K Buy
8,009
+168
+2% +$1.92K ﹤0.01% 5711
2021
Q2 		$108K Buy
7,841
+4,881
+165% +$75.4K ﹤0.01% 5515
2021
Q1 		$41K Buy
2,960
+27
+0.9% +$559 ﹤0.01% 5580
2020
Q4 		$95K Buy
+2,933
New +$67.9K ﹤0.01% 5009

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

JP Morgan Chase's ONCR Position: Q2 2023 in Review

JP Morgan Chase sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 353 shares.

JP Morgan Chase first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $243K in Q4 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • JP Morgan Chase reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Chase sold 353 Oncorus, Inc. shares in Q2 2023.
  • JP Morgan Chase first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
  • JP Morgan Chase's Oncorus, Inc. position peaked at $243K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.